EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING
PRIDE
PROSPECTIVE EVALUATION OF THE IDASCORE ALGORITHM FOR EMBRYO RANKING
1 other identifier
interventional
1,325
1 country
1
Brief Summary
This study aims to investigate whether embryo ranking by a fully automated AI tool (iDAScore) results in a similar transfer-to-pregnancy compared to manual embryo ranking by an embryologist. IVF patients who are planned for a freeze-all approach (where all usable embryos are frozen and transferred in later transfer cycles) will be allocated to either the control (ranking by embryologist) or intervention arm (ranking by iDAScore). The frozen embryos will be warmed and transferred one by one, according to their assigned rank. We want to see if the average number of embryo transfers that is needed to achieve a clinical pregnancy (transfer-to-pregnancy) is similar in both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pregnancy
Started Dec 2025
Longer than P75 for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2025
CompletedFirst Posted
Study publicly available on registry
September 23, 2025
CompletedStudy Start
First participant enrolled
December 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2029
December 23, 2025
December 1, 2025
3 years
September 4, 2025
December 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Transfer to pregnancy
Number of embryo transfers performed until a clinical pregnancy is obtained
The patient is followed up for clinical pregnancy outcomes (7-week echo) up until 1 year after the oocyte retrieval date, or until the result of the last available embryo is known.
Secondary Outcomes (4)
iDA-embryologist consensus
Embryo ranking is done on day 5 and/or 6 of embryo development and can be immediately compared during ranking.
Embryo prioritization time
Measures the time elapsing between the start and end of embryo prioritisation (range of minutes). Is recorded on day 5 and day 6 of embryo development right after embryo evaluation.
Cumulative clinical pregnancy rate
Up until 1 year after oocyte retrieval
Clinical pregnancy rate after the first embryo transfer
Clinical pregnancy is determined at the 7 week echo by detection of a fetal heart beat.
Study Arms (2)
Embryologist ranking
NO INTERVENTIONEmbryologist ranks the embryos according to their appearance
iDA ranking
EXPERIMENTALAI tool ranks embryos based on fully automated analysis of time-lapse images
Interventions
iDAScore® is a deep learning-based tool that provides fully automated analysis of embryo time-lapse images. It automatically generates a score (1-9.9) for each embryo in the patient's embryo cohort, which correlates to the likelihood of achieving a fetal heartbeat (clinical pregnancy).
Eligibility Criteria
You may qualify if:
- patients undergoing an ICSI/IVF treatment (with donor or own oocytes) that are planned for a 'freeze-all' strategy on day 5
- all types of sperm samples (ejaculated or testicular, fresh or frozen, partner or donor origin)
- Minimum 8 follicles (≥ 12 mm) on last follicular measurement before oocyte retrieval
- ≤ Age ≤ 42 years
- ≤ BMI ≤ 35 kg/m²
- Maximum third IVF/ICSI cycle
- Participants can be included only once in the trial
You may not qualify if:
- Embassy patients
- Use of frozen oocytes
- In vitro maturation (IVM) cycles
- Pre-implantation genetic Testing (PGT) cycles
- Proven untreated intra-uterine pathologies (e.g. Asherman syndrome, adenomysosis)
- Endometriosis stage 3/4
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brussels IVF, UZ Brussel
Brussels, Brussels Capital, 1090, Belgium
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Praet, M.D.
Brussels IVF, UZ Brussel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2025
First Posted
September 23, 2025
Study Start
December 11, 2025
Primary Completion (Estimated)
December 11, 2028
Study Completion (Estimated)
October 1, 2029
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share